SD
Srikripa Devarakonda Truist Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Regeneron Pharmaceuticals
REGN
$60.8B
| $573.38 | $812 |
42%
upside
| Buy | 26 days ago |
|
2
Incyte
INCY
$16.9B
| $86.64 | $79 |
9%
downside
| Hold | 1 month ago |
|
3
Arvinas
ARVN
$575M
| $7.83 | $11 |
40%
upside
| Hold | 4 months ago |
|
4
Biogen
BIIB
$20.6B
| $140.67 | $199 |
41%
upside
| Buy | 4 months ago |
|
5
Keros Therapeutics
KROS
$633M
| $15.59 | $25 |
60%
upside
| Buy | 5 months ago |
|
6
Protagonist Therapeutics
PTGX
$3.77B
| $60.53 | $76 |
26%
upside
| Buy | 5 months ago |
|
7
Eli Lilly
LLY
$652B
| $727.21 | $1,038 |
43%
upside
| Buy | 7 months ago |
|
8
AbbVie
ABBV
$375B
| $212.56 | $217 |
2%
upside
| Buy | 7 months ago |
|
9
Pfizer
PFE
$141B
| $24.88 | $32 |
29%
upside
| Buy | 8 months ago |
|
10
Edgewise Therapeutics
EWTX
$1.64B
| $15.57 | $50 |
221%
upside
| Buy | 9 months ago |
|
11
Scholar Rock
SRRK
$3.02B
| $31.41 | $45 |
43%
upside
| Buy | 9 months ago |
|
12
Kymera Therapeutics
KYMR
$3.11B
| $43.51 | $53 |
22%
upside
| Buy | 10 months ago |
|
13
Verastem
VSTM
$663M
| $10.77 | $15 |
39%
upside
| Buy | 1 year ago |
|
14
Nurix Therapeutics
NRIX
$758M
| $9.91 | $36 |
263%
upside
| Buy | 1 year ago |
|
15
Cytokinetics
CYTK
$6.34B
| $53.01 | $70 |
32%
upside
| Buy | 1 year ago |
|
|
16
Incyte
INCY
$16.9B
| $86.64 | $100 |
15%
upside
| Buy | 2 years ago |
|